About one in eight adults (12%) say that they’re at the moment taking a GLP-1 drug resembling Ozempic or Wegovy both to shed weight or deal with a continual situation, a rise from 18 months in the past, although the excessive prices of the drugs stay a priority, a new KFF Health Tracking Poll finds.
Total practically one in 5 adults (18%) say sooner or later they’ve taken a GLP-1 drug, a category of medicines used for weight reduction and to deal with diabetes, coronary heart illness, and different continual circumstances.
Girls are extra seemingly than males to say they’re at the moment taking GLP-1 medicine (15% vs. 9%). Throughout age teams, present GLP-1 use is highest amongst adults ages 50-64 (22%). Decrease use amongst these ages 65 and older (9%) seemingly displays Medicare’s lack of protection for medicine prescribed particularly for weight reduction.
GLP-1 medicine have been utilized by massive shares of adults who say they’ve been identified with diabetes (57% have ever used the drug, together with 45% who’re at the moment utilizing), coronary heart illness (40% ever, 29% at the moment), or as overweight or obese up to now 5 years (34% ever, 23% at the moment).
Whereas most adults who’ve taken GLP-1 medicine say their insurance coverage lined at the least part of the price of these medicine, a couple of quarter (27%) of customers with medical health insurance say they paid the complete value of the medicine themselves.
The ballot – fielded previous to President Trump’s announcement final week associated to the associated fee and protection of GLP-1 medicine – finds that about half of GLP-1 customers (56%), together with the same share amongst these with insurance coverage (55%), say that it was tough to afford these medicine.
As well as, amongst adults who’ve ever taken GLP-1 medicine, value is without doubt one of the mostly cited causes for stopping. Total, 14% of GLP-1 customers say they’re now now not utilizing the drugs attributable to the price of the medicine. An identical share cite the medicine’ uncomfortable side effects (13%), whereas fewer say they stopped as a result of their situation improved (5%).
Most Do Not Anticipate Trump Administration to Decrease Drug Costs for Folks Like Them
Many of the public has heard little or nothing about latest Trump administration announcement aimed toward addressing drug costs, together with offers to decrease what drug makers cost state Medicaid applications, a deal to decrease the price of in vitro fertilization (IVF) medicine, and plans for a web site referred to as TrumpRx that will permit folks to purchase medicine immediately from producers with out utilizing their medical health insurance.
When requested about whether or not they anticipated the Trump administration’s insurance policies to decrease the price of prescribed drugs for folks like them, most (62%) say it’s both “not too seemingly” or “by no means seemingly,” whereas practically 4 in 10 (38%) say it’s “very” or “considerably seemingly.”
These expectations are largely pushed by partisanship. Giant majorities of Republicans (73%) and MAGA supporters (83%) say it’s seemingly that the Trump administration will decrease drug costs for folks like them, whereas far fewer independents (33%) and only one in 10 Democrats (9%) say that it’s seemingly.
Medicare enrollees usually tend to assume the Trump administration insurance policies will assist folks like them. About half (49%) of adults ages 65 and older with Medicare say they assume it’s seemingly that the Trump administration will decrease their prescription drug prices, in comparison with smaller shares of adults below age 65 with employer-sponsored insurance coverage (34%) or Medicaid (32%).
Different findings embody:
- Total, about one in 4 (26%) adults say they or somebody of their family had issues paying for prescribed drugs up to now 12 months. The shares are greater amongst uninsured adults (41%), Hispanic adults (33%), Black adults (32%), and people with annual family incomes under $40,000 (33%).
- Most individuals who’ve taken GLP-1 medicine say they bought them from one in all their medical doctors (76%), whereas about one in six (17%) say they bought them from an internet supplier or web site, and one in ten (9%) report getting them from a medical spa or aesthetic medical heart.
- Amongst individuals who haven’t taken a GLP-1 drug, about one in 5 (22%) say they might be excited about taking a GLP-1 drug to shed weight, together with 7% who say they might be “very .” Girls are extra seemingly than males to say they might be at the least considerably excited about taking these medicine to shed weight (27% v. 18%). Curiosity rises to 4 in ten (43%) amongst adults who’ve been identified as overweight or obese however aren’t at the moment taking these medicine.
Designed and analyzed by public opinion researchers at KFF, this survey was carried out October 27-November 2, 2025, on-line and by phone amongst a nationally consultant pattern of 1,350 U.S. adults in English and in Spanish. The margin of sampling error is plus or minus 3 proportion factors for the complete pattern. For outcomes primarily based on different subgroups, the margin of sampling error could also be greater.
